• Glucagon-like peptide 1 receptor agonists (GLP-1) (medicines used to lower blood glucose) probably reduce the risk of death due to any cause but may have little or no death due to a heart attack in ...

It’s possible that GLP-1s may be useful for a range of substance use disorders, including opioid use disorder and nicotine ...

which can help to speed up our understanding of how treatments may work for a new health condition.” GLP-1 receptor agonists may influence the very mechanisms within the brain that regulate ...

receptor agonists. These medications mimic the action of the natural hormone GLP-1, which the gut releases after eating. This article asks whether peptides really work for weight loss, discusses ...

Even as millions of older adults clamor for drugs such as Ozempic and Wegovy, monthly use of the medications known as GLP-1 receptor agonists soared ... “These medications work from a weight ...

Semaglutide's role extends beyond diabetes, aiding weight loss and offering cardiovascular protection, with ongoing research ...

Mounjaro is a type of drug called a dual glucose-dependent insulinotropic polypeptide (GIP) and glucagon-like peptide-1 (GLP-1) receptor agonist ... Mounjaro does not cause hair loss as a side ...

A new study adds to a growing body of research suggesting a potential link between popular GLP-1 medications like Ozempic and ...

A new study suggests that medications that have transformed the treatment of obesity may also help people drink less alcohol.

If the CMS rule to cover obesity medications is finalized, coverage will increase by other insurers, experts predicted. HHS ...